prof. dr. G.A. Huls

No picture available
E-mail:
g.huls umcg.nl

Research

Postal address:
Netherlands
  1. 2020
  2. Dutch-Belgian Hemato-Oncology, Swiss Grp Clinical Canc Res SAKK, Ossenkoppele, G. J., Breems, D. A., Stuessi, G., Van Norden, Y., ... Lowenberg, B. (2020). Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia. https://doi.org/10.1038/s41375-020-0725-0
  3. 2019
  4. Huls, G., Chitu, D. A., Havelange, V., Jongen-Lavrencic, M., van de Loosdrecht, A. A., Biemond, B. J., ... Löwenberg, B. (2019). Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients. Blood, 1457-1464. https://doi.org/10.1182/blood-2018-10-879866
  5. de Kort, E. A., de Lil, H. S., Bremmers, M. E. J., van Groningen, L. F. J., Blijlevens, N. M. A., Huls, G., ... van der Velden, W. J. F. M. (2019). Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation. PLoS ONE, 14(3), [0213913]. https://doi.org/10.1371/journal.pone.0213913
  6. Hout, F. E. M. I., van Duren, J., Monteferrario, D., Brinkhuis, E., Mariani, N., Westers, T. M., ... Huls, G. (2019). TCF4 promotes erythroid development. Experimental Hematology, 69, 17-21. https://doi.org/10.1016/j.exphem.2018.10.002
  7. 2018
  8. Riley, L. G., Heeney, M. M., Rudinger-Thirion, J., Frugier, M., Campagna, D. R., Zhou, R., ... Fleming, M. D. (2018). The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica, 103(12), 2008-2015. https://doi.org/10.3324/haematol.2017.182659
  9. Huls, G., Lowenberg, B., van de Loosdrecht, A. A., Janssen, J. J. W. M., Jongen-Lavrencic, M., Raaijmakers, M., ... Ossenkoppele, G. (2018). Richtlijn Acute promyelocytenleukemie (APL): richtlijnen voor diagnostiek en behandeling. Nederlands Tijdschrift voor Hematologie, 15(8), 396-401.
  10. Ustun, C., Morgan, E., Moodie, E. E. M., Pullarkat, S., Yeung, C., Broesby-Olsen, S., ... Borthakur, G. (2018). Core-binding factor acute myeloid leukemia with t(8;21) Risk factors and a novel scoring system (I-CBFit). Cancer medicine, 7(9), 4447-4455. https://doi.org/10.1002/cam4.1733
  11. Marneth, A. E., Botezatu, L., Hoenes, J. M., Israel, J. C. L., Schuette, J., Vassen, L., ... Khandanpour, C. (2018). GFI1 is required for RUNX1/ETO positive acute myeloid leukemia. Haematologica, 103(9), E395-E399. https://doi.org/10.3324/haematol.2017.180844
  12. Cany, J., Roeven, M. W. H., Evert, J. S. H., Hobo, W., Maas, F., Fernandez, R. F., ... Dolstra, H. (2018). Decitabine enhances targeting of AML cells by CD34(+) progenitor-derived NK cells in NOD/SCID/IL2Rg(null) mice. Blood, 131(2), 202-214. https://doi.org/10.1182/blood-2017-06-790204
  13. 2017
  14. de Swart, L., Reiniers, C., Bagguley, T., van Marrewijk, C., Bowen, D., Hellstrom-Lindberg, E., ... EUMDS Steering Committee (2017). Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. Haematologica, 103(1), 69-79. https://doi.org/10.3324/haematol.2017.171884
  15. da Silva-Coelho, P., Kroeze, L. I., Yoshida, K., Koorenhof-Scheele, T. N., Knops, R., van de Locht, L. T., ... Jansen, J. H. (2017). Clonal evolution in myelodysplastic syndromes. Nature Communications, 8, [15099]. https://doi.org/10.1038/ncomms15099
  16. 2016
  17. MC Langemeijer, S., Mariani, N., Knops, R., Gilissen, C., Woestenenk, R., de Witte, T., ... Jansen, J. H. (2016). Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients. PLoS ONE, 11(11), [e0165582]. https://doi.org/10.1371/journal.pone.0165582
  18. Satchwell, T. J., Bell, A. J., Hawley, B. R., Pellegrin, S., Mordue, K. E., van Deursen, C. T. B. M., ... Toye, A. M. (2016). Severe Ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts. Haematologica, 101(9), 1018-1027. https://doi.org/10.3324/haematol.2016.146209
  19. 2015
  20. te Boome, L. C. J., Mansilla, C., van der Wagen, L. E., Lindemans, C. A., Petersen, E. J., Spierings, E., ... Kuball, J. (2015). Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. Leukemia, 29(9), 1839-1846. https://doi.org/10.1038/leu.2015.89
  21. Cornelissen, J. J., Versluis, J., Passweg, J. R., van Putten, W. L. J., Manz, M. G., Maertens, J., ... SAKK Leukemia Grp (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5), 1041-1050. https://doi.org/10.1038/leu.2014.332
Previous 1 2 Next

ID: 437235